Elysium Health Inc, a life sciences company focused on ageing research, announced on Thursday the launch of collagen supplement COFACTOR.

COFACTOR is designed to deliver complete support by providing the building blocks to increase collagen production and by addressing multiple root causes of collagen decline -- aged fibroblasts, decline in NAD+, and decline in hyaluronic acid (HA). Its unique formulation combines grass-fed collagen peptides with the clinically proven NAD+ booster nicotinamide riboside (NR), hyaluronic acid (HA), and the essential collagen cofactor vitamin C, which together make up its 4-in-1 system.

Elysium Health CEO Eric Marcotulli said: "The global collagen market is projected to reach USD14.4bn by 2033, driven by rising health awareness, increasing demand for functional foods and supplements, and interest in skin care and joint health products. Even so, we were unable to identify any available products that address key drivers of collagen decline, including ageing. We developed Cofactor to offer a comprehensive solution -- addressing several root causes of ageing that impact collagen synthesis, loss, and degradation."